How China’s trade surplus is floating Hong Kong equities, even as Western bulls retreat
"The one thing that professional investors or sophisticated investors fear the most is uncertainty." Rene Vanguestaine
China’s AI regulation debate enters the agent era
As AI shifts from generating content to taking action, it is no longer just a technology story — but a governance challenge By Vivian Toh China’s annual “Two Sessions”…
Regulatory caution dims Hong Kong SPAC outlook, while Chinese tastes drive out foreign brands
Hong Kong has completed just its third listing using a SPAC since the program's launch four years ago. Why has uptake been so anemic? And Hong Kong's popular Mannings health and beauty chain is pulling out of Mainland China after more than two decades in the market. Why is it calling it quits?
Nasdaq gets tough on small Chinese IPOs, as an AI-fueled energy storage boom takes off
For a market that basically prides itself on protecting investors… I have to say I'm amazed that it has taken so long.
Hong Kong: China’s IPO pipeline and crypto lab
Companies raised $13.6 billion through Hong Kong IPOs in the first half of the year, giving the city the global fundraising title for that period. What's behind the sudden boom? And a growing number of Chinese companies are experimenting with cryptocurrencies in Hong Kong, even as such currencies are banned on the Mainland. What's driving such different approaches on the Mainland and in Hong Kong?
PODCAST: A Bubble Tea IPO Freeze, and a Revenue-less Drug Maker
China's securities regulator puts the brakes on new bubble tea IPOs in Hong Kong. Is this China's latest step to assert its authority over the former British colony? And former drug making highflyer Ascletis has become revenue-less after its earlier drugs fizzled. Now the company is hoping to revive its fortunes with a new weight-loss drug from the same class as Ozempic.
PODCAST: WeRide’s Spin with Uber, and Starbucks’ New China CEO
Uber will offer WeRide robotaxi services starting in the UAE. Is this a big deal, or mostly symbolic? And Starbucks names a new China CEO to revive its flagging local operation. Will that be enough to tackle the challenge from low-price companies like Luckin and Cotti?
Recent Articles
RELATED ARTICLES
-
Move over, Hong Kong. Young Beijing Exchange becomes China’s new IPO hub
- China’s chip consolidation accelerates with SMIC, Hua Hong buyouts
- Policy forces shift offshore Chinese IPO tide to Hong Kong from New York
- China’s franchising boom cooks up new giants, leaves mid-tier Western chains behind
-
Meta cuts Manus free from China, as regional lender gets premium bailout
META.US
- 15th Five-Year Plan: Opportunities and trade-offs under technological self-reliance
- Regulatory caution dims Hong Kong SPAC outlook, while Chinese tastes drive out foreign brands
